New Studies Move Topical Minocycline Foam for Rosacea Closer To Approval
One year ago - By Surgical Aesthetics Magazine
Two phase 3 studies of Foamix Pharmaceuticals' FMX103 were published in the Journal of the American Academy of Dermatology. Foamix conducted FX2016-11 and FX2016-12 to support the New Drug Application submission of FMX103, which is currently under review by the U.S. Food and Drug Administration for the treatment of moderate-to-severe papulopustular rosacea in adults.
Both studies demonstrated high statistically significant superiority of FMX103 compared with vehicle in both primary endpoints of absolute inflammatory lesion reduction and Investigator's Global Assessment treatment success at...
Read more ...
The headlines of Master Doctor
Cosmetic surgeon faces legal action over operation on teenager's labia
A Melbourne cosmetic surgeon faces civil court action over the removal of a 13-year-old girl's labia that allegedly left her disfigured and suffering serious psychological trauma.
How Can Women Benefit From Laser Hair Removal During Summertime?
3 Minute Read: Summertime often means trips to the beach and laying out by the pool. Having to shave before every event or gathering can be time-consuming and inconvenient. We...
Dedicated cGMP Facility for Porous Plastic Components
Porvair Sciences reports investment in a dedicated clean area for manufacturing Vyon® porous plastic components for healthcare, pharmaceutical and life science products.